{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:06:07Z","timestamp":1762963567906,"version":"3.45.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02012-5","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:05:25Z","timestamp":1762959925000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Radiomic imaging models for predicting breast cancer prognosis based on Interleukin-18 (IL18)"],"prefix":"10.1186","volume":"25","author":[{"given":"Qian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiahui","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2012_CR1","first-page":"1","volume":"4","author":"JA Zujewski","year":"2018","unstructured":"Zujewski JA, Dvaladze AL, Ilbawi A, et al. Knowledge summaries for comprehensive breast cancer control. J Glob Oncol. 2018;4:1\u20137.","journal-title":"J Glob Oncol"},{"issue":"12","key":"2012_CR2","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/S1470-2045(24)00523-0","volume":"25","author":"T Hughes","year":"2024","unstructured":"Hughes T, Harper A, Gupta S, et al. The current and future global burden of cancer among adolescents and young adults: a population-based study. Lancet Oncol. 2024;25(12):1614\u201324.","journal-title":"Lancet Oncol"},{"key":"2012_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","volume":"286\u2013287","author":"D Sonkin","year":"2024","unstructured":"Sonkin D, Thomas A, Teicher BA. Cancer treatments: Past, present, and future. Cancer Genet. 2024;286\u2013287:18\u201324.","journal-title":"Cancer Genet"},{"issue":"2","key":"2012_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.21147\/j.issn.1000-9604.2025.02.12","volume":"37","author":"H Liu","year":"2025","unstructured":"Liu H, Dilger JP. Different strategies for cancer treatment: targeting cancer cells or their neighbors? Chin J Cancer Res. 2025;37(2):289\u201392.","journal-title":"Chin J Cancer Res"},{"key":"2012_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0083-6729(06)74009-2","volume":"74","author":"D Boraschi","year":"2006","unstructured":"Boraschi D, Tagliabue A. The interleukin-1 receptor family. Vitam Horm. 2006;74:229\u201354.","journal-title":"Vitam Horm"},{"issue":"10","key":"2012_CR6","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1286-4579(00)01279-X","volume":"2","author":"I Sugawara","year":"2000","unstructured":"Sugawara I. Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens. Microbes Infect. 2000;2(10):1257\u201363.","journal-title":"Microbes Infect"},{"issue":"6","key":"2012_CR7","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1164\/ajrccm.161.6.9911054","volume":"161","author":"G Yamada","year":"2000","unstructured":"Yamada G, Shijubo N, Shigehara K, et al. Increased levels of Circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med. 2000;161(6):1786\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2012_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.actatropica.2003.10.005","volume":"89","author":"S Kojima","year":"2004","unstructured":"Kojima S, Nagamine Y, Hayano M, et al. A potential role of Interleukin 18 in severe falciparum malaria. Acta Trop. 2004;89(3):279\u201384.","journal-title":"Acta Trop"},{"issue":"4","key":"2012_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1684\/ecn.2018.0401","volume":"28","author":"M Esmailbeig","year":"2017","unstructured":"Esmailbeig M, Ghaderi A. Interleukin-18: a regulator of cancer and autoimmune diseases. Eur Cytokine Netw. 2017;28(4):127\u201340.","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"2012_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1365-2567.2004.01810.x","volume":"111","author":"W Walker","year":"2004","unstructured":"Walker W, Rotondo D. Prostaglandin E2 is a potent regulator of interleukin-12- and interleukin-18-induced natural killer cell interferon-gamma synthesis. Immunology. 2004;111(3):298\u2013305.","journal-title":"Immunology"},{"key":"2012_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.npep.2016.11.002","volume":"64","author":"A Koller","year":"2017","unstructured":"Koller A, Bianchini R, Schlager S, et al. The neuropeptide Galanin modulates natural killer cell function. Neuropeptides. 2017;64:109\u201315.","journal-title":"Neuropeptides"},{"key":"2012_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3389\/fimmu.2018.00776","volume":"9","author":"MD Lacher","year":"2018","unstructured":"Lacher MD, Bauer G, Fury B, et al. SV-BR-1-GM, a clinically effective GM-CSF-Secreting breast cancer cell Line, expresses an immune signature and directly activates CD4(+) T lymphocytes. Front Immunol. 2018;9:776.","journal-title":"Front Immunol"},{"issue":"2","key":"2012_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.sult.2022.02.003","volume":"43","author":"E Avery","year":"2022","unstructured":"Avery E, Sanelli PC, Aboian M, et al. Radiomics: A primer on processing workflow and analysis. Semin Ultrasound CT MR. 2022;43(2):142\u20136.","journal-title":"Semin Ultrasound CT MR"},{"issue":"11","key":"2012_CR14","first-page":"801","volume":"40","author":"Q Li","year":"2018","unstructured":"Li Q, Ye ZX. [Radiomics: the process and applications in tumor research]. Zhonghua Zhong Liu Za Zhi. 2018;40(11):801\u20134.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"2012_CR15","doi-asserted-by":"crossref","unstructured":"Maniaci A, Lavalle S, Gagliano C, et al. The integration of radiomics and artificial intelligence in modern medicine. Life (Basel) 2024, 14(10).","DOI":"10.3390\/life14101248"},{"issue":"9","key":"2012_CR16","doi-asserted-by":"publisher","first-page":"e644","DOI":"10.1016\/j.crad.2023.05.012","volume":"78","author":"A Wang","year":"2023","unstructured":"Wang A, Xu H, Zhang C, et al. Radiomic analysis of MRI for prediction of response to induction chemotherapy in nasopharyngeal carcinoma patients. Clin Radiol. 2023;78(9):e644\u201353.","journal-title":"Clin Radiol"},{"issue":"3","key":"2012_CR17","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5582\/bst.2024.01121","volume":"18","author":"L Chen","year":"2024","unstructured":"Chen L, Yin G, Wang Z, et al. A predictive radiotranscriptomics model based on DCE-MRI for tumor immune landscape and immunotherapy in cholangiocarcinoma. Biosci Trends. 2024;18(3):263\u201376.","journal-title":"Biosci Trends"},{"issue":"1","key":"2012_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/jso.23655","volume":"110","author":"FM Knuttel","year":"2014","unstructured":"Knuttel FM, Menezes GL, van den Bosch MA, et al. Current clinical indications for magnetic resonance imaging of the breast. J Surg Oncol. 2014;110(1):26\u201331.","journal-title":"J Surg Oncol"},{"issue":"4","key":"2012_CR19","first-page":"751","volume":"30","author":"M Radulovic","year":"2024","unstructured":"Radulovic M, Li X, Djuricic GJ, et al. Bridging histopathology and radiomics toward prognosis of metastasis in early breast cancer. Microsc Microanal. 2024;30(4):751\u20138.","journal-title":"Microsc Microanal"},{"key":"2012_CR20","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fonc.2018.00630","volume":"8","author":"A Chaddad","year":"2018","unstructured":"Chaddad A, Niazi T, Probst S, et al. Predicting Gleason score of prostate cancer patients using radiomic analysis. Front Oncol. 2018;8:630.","journal-title":"Front Oncol"},{"issue":"1","key":"2012_CR21","doi-asserted-by":"publisher","first-page":"16232","DOI":"10.1038\/s41598-021-95643-x","volume":"11","author":"D Kawahara","year":"2021","unstructured":"Kawahara D, Imano N, Nishioka R, et al. Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis. Sci Rep. 2021;11(1):16232.","journal-title":"Sci Rep"},{"issue":"11","key":"2012_CR22","doi-asserted-by":"publisher","first-page":"4419","DOI":"10.1016\/j.acra.2024.04.003","volume":"31","author":"J Gou","year":"2024","unstructured":"Gou J, Li J, Li Y, et al. The diagnostic accuracy between radiomics model and Non-radiomics model for preoperative of microvascular invasion of solitary hepatocellular carcinoma: A systematic review and Meta-analysis. Acad Radiol. 2024;31(11):4419\u201333.","journal-title":"Acad Radiol"},{"issue":"4","key":"2012_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.29271\/jcpsp.2024.04.400","volume":"34","author":"Z Sun","year":"2024","unstructured":"Sun Z, Zhou Z, Wang L, et al. IVIM and DCE-MRI in predicting phenotypic subtypes and Nottingham prognostic index of breast cancer. J Coll Physicians Surg Pak. 2024;34(4):400\u20136.","journal-title":"J Coll Physicians Surg Pak"},{"issue":"4","key":"2012_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314\u20136.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"2012_CR25","doi-asserted-by":"publisher","first-page":"1902880","DOI":"10.1002\/advs.201902880","volume":"7","author":"YR Miao","year":"2020","unstructured":"Miao YR, Zhang Q, Lei Q, et al. ImmuCellAI: A unique method for comprehensive T-Cell subsets abundance prediction and its application in cancer immunotherapy. Adv Sci (Weinh). 2020;7(7):1902880.","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"2012_CR26","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.ygeno.2004.08.005","volume":"84","author":"K Tu","year":"2004","unstructured":"Tu K, Yu H, Guo Z, et al. Learnability-based further prediction of gene functions in gene ontology. Genomics. 2004;84(6):922\u20138.","journal-title":"Genomics"},{"key":"2012_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/0470857897.ch8","volume":"247","author":"M Kanehisa","year":"2002","unstructured":"Kanehisa M. The KEGG database. Novartis Found Symp. 2002;247:91\u2013101. discussion 101\u2013103, 119\u2013128, 244\u2009\u2013\u2009152.","journal-title":"Novartis Found Symp"},{"issue":"1","key":"2012_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"key":"2012_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-1-59745-515-2_6","volume":"396","author":"KF Aoki-Kinoshita","year":"2007","unstructured":"Aoki-Kinoshita KF, Kanehisa M. Gene annotation and pathway mapping in KEGG. Methods Mol Biol. 2007;396:71\u201391.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"2012_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jech.51.5.579-a","volume":"51","author":"L Prieto","year":"1997","unstructured":"Prieto L, Lamarca R, Casado A, et al. The evaluation of agreement on continuous variables by the intraclass correlation coefficient. J Epidemiol Community Health. 1997;51(5):579\u201381.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"2012_CR31","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s00330-021-08254-5","volume":"32","author":"J Hou","year":"2022","unstructured":"Hou J, Li H, Zeng B, et al. MRI-based radiomics nomogram for predicting Temporal lobe injury after radiotherapy in nasopharyngeal carcinoma. Eur Radiol. 2022;32(2):1106\u201314.","journal-title":"Eur Radiol"},{"issue":"1","key":"2012_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12967-020-02215-0","volume":"18","author":"M Li","year":"2020","unstructured":"Li M, Zhang J, Dan Y, et al. A clinical-radiomics nomogram for the preoperative prediction of lymph node metastasis in colorectal cancer. J Transl Med. 2020;18(1):46.","journal-title":"J Transl Med"},{"issue":"1","key":"2012_CR33","doi-asserted-by":"publisher","first-page":"e0314745","DOI":"10.1371\/journal.pone.0314745","volume":"20","author":"H Liu","year":"2025","unstructured":"Liu H, Karsidag M, Chhatwal K, et al. Single-cell and bulk RNA sequencing analysis reveals CENPA as a potential biomarker and therapeutic target in cancers. PLoS ONE. 2025;20(1):e0314745.","journal-title":"PLoS ONE"},{"issue":"8","key":"2012_CR34","first-page":"4074","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H. Pan-cancer profiles of the Cuproptosis gene set. Am J Cancer Res. 2022;12(8):4074\u201381.","journal-title":"Am J Cancer Res"},{"key":"2012_CR35","doi-asserted-by":"publisher","first-page":"108302","DOI":"10.1016\/j.pharmthera.2022.108302","volume":"240","author":"H Liu","year":"2022","unstructured":"Liu H, Dilger JP, Lin J. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers. Pharmacol Ther. 2022;240:108302.","journal-title":"Pharmacol Ther"},{"issue":"3\u20134","key":"2012_CR36","first-page":"CBM240119","volume":"41","author":"AM Rasteh","year":"2024","unstructured":"Rasteh AM, Liu H, Wang P. Pan-cancer genetic profiles of mitotic DNA integrity checkpoint protein kinases. Cancer Biomark. 2024;41(3\u20134):CBM240119.","journal-title":"Cancer Biomark"},{"key":"2012_CR37","doi-asserted-by":"publisher","first-page":"858756","DOI":"10.3389\/fonc.2022.858756","volume":"12","author":"H Liu","year":"2022","unstructured":"Liu H, Weng J. A Pan-Cancer bioinformatic analysis of RAD51 regarding the values for Diagnosis, Prognosis, and therapeutic prediction. Front Oncol. 2022;12:858756.","journal-title":"Front Oncol"},{"key":"2012_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cancergen.2023.10.001","volume":"278\u2013279","author":"H Liu","year":"2023","unstructured":"Liu H, Tang T. Pan-cancer genetic analysis of disulfidptosis-related gene set. Cancer Genet. 2023;278\u2013279:91\u2013103.","journal-title":"Cancer Genet"},{"key":"2012_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1600-065X.2008.00624.x","volume":"223","author":"WP Arend","year":"2008","unstructured":"Arend WP, Palmer G, Gabay C. IL-1, IL-18, and IL-33 families of cytokines. Immunol Rev. 2008;223:20\u201338.","journal-title":"Immunol Rev"},{"key":"2012_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2369-13-75","volume":"13","author":"AE Grzegorzewska","year":"2012","unstructured":"Grzegorzewska AE, Wobszal PM, Mostowska A, et al. Antibodies to hepatitis B virus surface antigen and Interleukin 12 and Interleukin 18 gene polymorphisms in Hemodialysis patients. BMC Nephrol. 2012;13:75.","journal-title":"BMC Nephrol"},{"key":"2012_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1746-6148-8-105","volume":"8","author":"MM Rahman","year":"2012","unstructured":"Rahman MM, Uyangaa E, Han YW, et al. Enhancement of Th1-biased protective immunity against avian influenza H9N2 virus via oral co-administration of attenuated Salmonella enterica serovar typhimurium expressing chicken interferon-alpha and interleukin-18 along with an inactivated vaccine. BMC Vet Res. 2012;8:105.","journal-title":"BMC Vet Res"},{"issue":"3","key":"2012_CR42","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2249.2004.02465.x","volume":"136","author":"SL Lorey","year":"2004","unstructured":"Lorey SL, Huang YC, Sharma V. Constitutive expression of interleukin-18 and interleukin-18 receptor mRNA in tumour derived human B-cell lines. Clin Exp Immunol. 2004;136(3):456\u201362.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"2012_CR43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1055\/s-0035-1559780","volume":"123","author":"JH Chung","year":"2015","unstructured":"Chung JH, Lee YC, Eun YG, et al. Single nucleotide polymorphism of Interleukin-18 and Interleukin-18 receptor and the risk of papillary thyroid cancer. Exp Clin Endocrinol Diabetes. 2015;123(10):598\u2013603.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"4","key":"2012_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/CJP.CJP_18_19","volume":"62","author":"YF Yang","year":"2019","unstructured":"Yang YF, Liang YJ. Adenine decreases hypertrophic effects through interleukin-18 receptor. Chin J Physiol. 2019;62(4):139\u201347.","journal-title":"Chin J Physiol"},{"issue":"9","key":"2012_CR45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s11547-022-01529-x","volume":"127","author":"G Chiti","year":"2022","unstructured":"Chiti G, Grazzini G, Flammia F, et al. Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a radiomic model to predict tumor grade. Radiol Med. 2022;127(9):928\u201338.","journal-title":"Radiol Med"},{"issue":"1","key":"2012_CR46","doi-asserted-by":"publisher","first-page":"14043","DOI":"10.1038\/s41598-022-18458-4","volume":"12","author":"M Musigmann","year":"2022","unstructured":"Musigmann M, Akkurt BH, Krahling H, et al. Assessing preoperative risk of STR in skull meningiomas using MR radiomics and machine learning. Sci Rep. 2022;12(1):14043.","journal-title":"Sci Rep"},{"issue":"7","key":"2012_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11547-022-01506-4","volume":"127","author":"D Caruso","year":"2022","unstructured":"Caruso D, Polici M, Rinzivillo M, et al. CT-based radiomics for prediction of therapeutic response to everolimus in metastatic neuroendocrine tumors. Radiol Med. 2022;127(7):691\u2013701.","journal-title":"Radiol Med"},{"issue":"12","key":"2012_CR48","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1007\/s00330-021-07971-1","volume":"31","author":"S Halligan","year":"2021","unstructured":"Halligan S, Menu Y, Mallett S. Why did European radiology reject my radiomic biomarker paper? How to correctly evaluate imaging biomarkers in a clinical setting. Eur Radiol. 2021;31(12):9361\u20138.","journal-title":"Eur Radiol"},{"issue":"3","key":"2012_CR49","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.radonc.2016.04.004","volume":"119","author":"TP Coroller","year":"2016","unstructured":"Coroller TP, Agrawal V, Narayan V, et al. Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol. 2016;119(3):480\u20136.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2012_CR50","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40644-019-0243-3","volume":"19","author":"S Chen","year":"2019","unstructured":"Chen S, Harmon S, Perk T, et al. Using neighborhood Gray tone difference matrix texture features on dual time point PET\/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules. Cancer Imaging. 2019;19(1):56.","journal-title":"Cancer Imaging"},{"issue":"3","key":"2012_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1148\/radiol.2021202553","volume":"298","author":"MR Tomaszewski","year":"2021","unstructured":"Tomaszewski MR, Gillies RJ. The biological meaning of radiomic features. Radiology. 2021;298(3):505\u201316.","journal-title":"Radiology"},{"key":"2012_CR52","doi-asserted-by":"crossref","unstructured":"Song X, Zhu Y, Geng W, et al. Spatial and single-cell transcriptomics reveal cellular heterogeneity and a novel cancer-promoting Treg cell subset in human clear-cell renal cell carcinoma. J Immunother Cancer 2025; 13(1).","DOI":"10.1136\/jitc-2024-010183"},{"issue":"8","key":"2012_CR53","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-023-06068-5","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Bai Y, Ma XX, et al. Clinical-mediated discovery of pyroptosis in CD8(+) T cell and NK cell reveals melanoma heterogeneity by single-cell and bulk sequence. Cell Death Dis. 2023;14(8):553.","journal-title":"Cell Death Dis"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02012-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02012-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T16:03:43Z","timestamp":1762963423000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-02012-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02012-5","relation":{},"ISSN":["1471-2342"],"issn-type":[{"type":"electronic","value":"1471-2342"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval nor informed consent was required. This study was conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}